Certara Down 15% After Announcing Stock Sale by Shareholders

By Josh Beckerman

Certara Inc. shares fell 15% to $17.24 after the biosimulation company said certain stockholders including EQT AB plan to sell 7 million shares.

On Tuesday, Certara said second-quarter revenue rose 18% to $82.8 million, but added that it expects foreign exchange impact and softness in regulatory services to continue in the second half of the year.